Shanghai Kinetic Medical Co., Ltd (SHE:300326)
China flag China · Delayed Price · Currency is CNY
6.17
+0.08 (1.31%)
Aug 14, 2026, 3:04 PM CST

Shanghai Kinetic Medical Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
869.21963.06984.52956.261,1661,269
Revenue Growth
-13.35%-2.18%2.96%-17.99%-8.08%19.50%
Gross Profit
451.22475.9479.09490.17740.07778.06
Operating Income
52.0259.9379.1279.78212.26280.36
Net Income
179.22134.89-105.57112.54-21.28161.78
Earnings Per Share
0.250.19-0.150.16-0.030.22
EPS Growth
------

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Medical Device Manufacturing
612.65559.41564.07850.89869.88
Medical Device Trading
100.11142.59155.63140.37194.9
Device Disinfection Service Industry
233.27260.74213.93155.01192.75
Unallocated Other Operations
17.0421.7822.6319.7711.06
Total
963.06984.52956.261,1661,269

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
1,6221,5171,2191,042971.89906.83
Total Debt
54.0154.22326.48196.83328.49425.62
Net Cash (Debt)
1,5681,462892.06844.84643.41481.21
Net Cash Growth
80.39%63.93%5.59%31.31%33.71%-10.92%
Net Cash Per Share
2.192.041.241.180.890.67

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
197.18189.09157.75274.26236.76378.16
Capital Expenditures
-43.88-66.2-82.84-53.79-41.45-49.21
Free Cash Flow
153.3122.8874.91220.47195.3328.94
Free Cash Flow Growth
68.01%64.04%-66.02%12.89%-40.63%28.84%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
51.91%49.41%48.66%51.26%63.47%61.33%
Operating Margin
5.99%6.22%8.04%8.34%18.20%22.10%
Pretax Margin
21.47%15.11%-11.21%13.97%-0.19%17.05%
Profit Margin
20.62%14.01%-10.72%11.77%-1.82%12.75%
FCF Margin
17.64%12.76%7.61%23.06%16.75%25.93%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.1000.100-0.060-0.050
Dividend Per Share Growth
0%----0%
Dividend Yield
1.64%1.79%-0.98%-0.49%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
24.6830.19-40.33-46.89
Forward PE
-32.9732.9725.8915.7326.00
P/FCF Ratio
28.8633.1462.2220.5926.4323.06
PS Ratio
5.094.234.734.754.435.98